Form SC 13G/A Ascendis Pharma A/S Filed by: T. Rowe Price Investment Management, Inc.
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
- H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
- Ascendis Pharma (ASND) PT Lowered to $326 at Stifel
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
